11 results found.

Breast Neoplasms, or Stomach Neoplasms Clinical Trial using Herceptin; afatinib; trastuzumab

Boehringer Ingelheim - Recruiting 18 years or older.
- Phase I Trial of Afatinib in Combination With 3 Weekly Trastuzumab in Patients With Tumours Overexpressing HER2. Once the MTD of Afatinib With 3 Weekly Trastuzumab Was Established the Safety of This Dose Will be Assessed Also in Combination With Weekly Trastuzumab..
Herceptin; afatinib; trastuzumab

Stomach Neoplasms; Esophageal Neoplasms; Metastatic Gastric Cance Clinical Trial using AUY922; BYL719

Novartis - Recruiting 18 years or older.
- A Phase IB, Multicenter, Open-label Dose Escalation Study of the PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer Carrying a Molecular Alteration of PIK3CA or an Amplification of HER2.
AUY922; BYL719

Sarcoma, Stomach Neoplasms, or Neoplasms Clinical Trial using Pazopanib; ARQ 197

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase Ib Study of the Combination of Pazopanib, an Oral VEGFR Inhibitor, and ARQ 197 (Tivantinib), an Oral MET Inhibitor, in Patients With Refractory Advanced Solid Tumors.
Pazopanib; ARQ 197

Stomach Neoplasms Clinical Trial using AMG 337

Amgen - Recruiting 18 years or older.
- A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors.
AMG 337

Breast Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms, Pancre Clinical Trial using ý1ýPb-TCMC-Trastuzumab; trastuzumab

Areva Med LLC - Recruiting 19 years or older.
- Phase I Trial of Intraperitoneal ý1ýPb-TCMC-Trastuzumab for HER-2 Expressing Malignancy.
ý1ýPb-TCMC-Trastuzumab; trastuzumab

Esophageal Cancer, Esophageal Dysplasia, Stomach Cancer, or Stoma Clinical Trial using Hybrid knife; IT knife

Xijing Hospital of Digestive Diseases - Recruiting 18 years to 80 years.
- Comparison of O-type Hybrid Knife and IT Knife in Endoscopic Submucosal Dissection for Upper Gastrointestinal Neoplasms: a Prospective Randomized Controlled Trial.
Hybrid knife; IT knife

Malnourished, Stomach Neoplasms, or Gastrointestinal Stromal Tumo Clinical Trial using Ensure powder

Seoul National University Hospital - Recruiting 20 years or older.
- A Prospective Randomized Controlled Trial Evaluating the Effects of Preoperative and Postoperative Oral Nutritional Supplements (ONS) in Malnourished Post-gastrectomy Patients.
Ensure powder

Stomach Neoplasms, Oesophageal Junction Cancer, or Lower Oesophag Clinical Trial using Epirubicin; Cisplatin; Paclitaxel; gastric surgery

Centre Hospitalier Universitaire de Besancon - Recruiting 18 years to 70 years.
- Preoperative Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel (Intensified PET) in Patients With Locally Gastric Cancer : a Phase II Proof-of-concept Study..
Epirubicin; Cisplatin; Paclitaxel; gastric surgery

Esophageal Neoplasms, or Stomach Neoplasms Clinical Trial using Docetaxel, Oxaliplatin; Radiotherapy

Johannes Gutenberg University Mainz - Recruiting 18 years to 75 years.
- Prospective, Open, Multicentre Phase I/II Study to Evaluate the Safety and Efficacy of a Neoadjuvant Radiochemotherapy With Docetaxel and Oxalipaltin in Patients With Adenocarcinoma of the Gastric-Oesophageal Junction.
Docetaxel, Oxaliplatin; Radiotherapy

Stomach Neoplasms Clinical Trial using S-1,oxaliplatin

National Cancer Center, Korea - Recruiting 18 years or older.
- A Randomized Phase II Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma.
S-1,oxaliplatin

Stomach Neoplasms Clinical Trial using S-1,Docetaxel

National Cancer Center, Korea - Recruiting 18 years to 70 years.
- Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer.
S-1,Docetaxel